NovaBridge Biosciences (IMAB) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Dec 15Dec 18Dec 23Dec 29Mar 10Mar 13Mar 18Mar 23

Key dataMar 23, 2026

Open$2.90

From 52W high−56.10%

Volume892600.00

Market cap$235.29M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataMar 23, 2026

Open

$2.90

From 52W high

−56.10%

Volume

892600.00

Market cap

$235.29M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−45.9x

P/E (TTM)

—

RSI (14)

29.1

MomentumView details →

1D Return

−0.69%

YTD Return

−28.54%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−45.9x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

8.0x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−19.42%

ROA (TTM)

−18.48%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

−100.00%

EPS YoY

+91.39%

FCF YoY

—

Revenue CAGR 3Y

−100.00%

EPS CAGR 3Y

+74.69%

EBITDA YoY

+95.82%

MomentumView details →

1D Return

−0.69%

YTD Return

−28.54%

1Y Return

+231.87%

RSI (14)

29.1

vs 50D SMA

−26.00%

vs 200D SMA

−6.18%

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

22.82x

Quick Ratio

22.82x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.25

EPS Surprise

−316.67%

Beats (12Q)

4/12

Next Q EPS Est

—

Avg Surprise (4Q)

−77.40%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−49.02M

Op. CF (TTM)

−34.30M

Latest newsMore news →

NovaBridge Biosciences reported financial results for the six months ended June 30, 2026, and provided a business update on pipeline momentum and strategic execution.31d ago

Similar companies

ALX Oncology Holdings Inc.ALXO Compugen Ltd.CGEN Niagen Bioscience IncNAGE YD Bio Limited Ordinary SharesYDES Whitehawk Therapeutics IncWHWK Immunotech Biopharm Ltd06978.HK Find similar companies →

Latest newsMore news →

NovaBridge Biosciences reported financial results for the six months ended June 30, 2026, and provided a business update on pipeline momentum and strategic execution.31d ago